Malaria Diagnostics Market Latest Trends ,Industry Growth And Future Scope Till 2025 | Grand View Research, Inc
“The global malaria diagnostics market size was valued at USD 628.5 million in 2017 and is anticipated to witness a CAGR of 4.5% during the forecast period .�
Global malaria diagnostics market size is expected to reach USD 888.77 million by 2025 expanding at a CAGR of 4.5% during the forecast period, according to Grand View Research, Inc. Rising cases of tropical diseases, developments in diagnostic techniques, and rising investments by local government and private firms are factors propelling the market growth. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions due to factors such as changing climate, underdeveloped healthcare infrastructure, and lack of advanced treatment options. Technological advancements in diagnostic testing has been crucial in disease management. Increasing number of government initiatives and R&D investments by market players are anticipated to fuel market potential in the near future. A large number of programs are being undertaken by major companies in order to reduce disease prevalence. For instance, Novartis Malaria Initiative was aimed at facilitating malaria elimination and control. The company has provided treatment to 750 million people across 60 countries without any profit. Thus, such initiatives are anticipated to facilitate the development of novel technologies and aid in market growth.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/malaria-diagnostics-market
Follow Us:
Further key findings from the study suggest:
Microscopy segment held the largest revenue share in 2017 due to wide usage of microscopic examination for the detection of malarial parasite
Rapid Diagnostic Tests (RDTs) would gain a considerable market share in near future owing to ease of use, convenience, and faster diagnosis offered by this technique
Molecular diagnostic tests are expected to witness the highest CAGR during the forecast period owing to their highly sensitive nature, accuracy, and capability of detecting low parasite count
The Africa region led the global market in 2017 on account of high disease incidence and subsequent adoption of various malarial diagnostic techniques
South East Asia held a considerable market share in 2017 owing to high disease reoccurrence and presence of a number of initiatives undertaken for disease control
Key companies in the market are Access Bio, Inc.; Alere, Inc.; Premier Medical Corporation Ltd.; Sysmex Partec GmbH; bioMérieux, Inc.; Beckman Coulter, Inc.; Siemens Healthineers; and Leica Microsystems GmbH.
Grand View Research has segmented the global malaria diagnostics market on the basis of technology and region: Malaria Diagnostics Technology Outlook (Revenue, USD Million, 2014 - 2025) Microscopy
Rapid Diagnostic Tests (RDT)
Molecular Diagnostic Tests o
Conventional PCR
o
Real-Time PCR
Malaria Diagnostics Regional Outlook (Revenue, USD Million, 2014 - 2025) Africa
o
Nigeria
o
Democratic Republic of the Congo
o
Uganda
South East Asia o
India
o
Myanmar
o
Indonesia
Eastern Mediterranean
Follow Us:
o
Saudi Arabia
o
Pakistan
Western Pacific o
China
o
Papua New Guinea
o
Cambodia
Americas o
Venezuela
o
Brazil
o
Colombia
Europe o
Turkey
o
France
o
U.K.
o
Germany
Browse Related Category Reports @ https://www.grandviewresearch.com/industry/clinical-diagnostics Table of Content of Malaria Diagnostics Market Chapter 1 Executive Summary Chapter 2 Research Methodology 2.1 Country Wise Market: Base Estimates 2.2 Global Market: CAGR Calculation 2.3 Region Based Segment Share Calculation 2.4 Research Scope & Assumptions 2.5 List of Data Sources 2.5.1 Data for primary interviews, by sources 2.5.2 Data for primary interviews, by region 2.6 Market Snapshot Chapter 3 Malaria Diagnostics Market Variables, Trends & Scope 3.1 Market Segmentation & Scope 3.2 Market Driver Analysis 3.2.1 Increasing demand for diagnostic tools in malaria endemic countries 3.2.2 Development of technologically advanced and efficient diagnostics
Follow Us:
3.2.3 Rising investment by government bodies, market players, and private investors to curb prevalence of malaria 3.3 Market Restraint Analysis 3.3.1 Increasing number of countries in malaria elimination phase 3.3.2 Demand for low cost malaria diagnostic tests 3.3.3 Key opportunities prioritized, by technology 3.4 Malaria Diagnostics Market - SWOT Analysis, by Factor (Political & Legal, Economic and Technological) 3.5 Industry Analysis - Porter’s 3.6 Malaria Diagnostics Market: Market Position Analysis, 2017 Chapter 4 Malaria Diagnostics Market: Technology Type Estimates & Trend Analysis 4.1 Malaria Diagnostics Market: Technology Type Movement Analysis 4.2 Microscopy 4.2.1 Microscopy market, 2014 - 2025 (USD Million) 4.3 Rapid Diagnostic Tests (RDT) 4.3.1 Rapid Diagnostic Tests (RDT) market, 2014 - 2025 (USD Million) 4.4 Molecular Diagnostic Tests 4.4.1 Molecular Diagnostic Tests market, 2014 - 2025 (USD Million) 4.4.1.1 Conventional PCR market, 2014 - 2025 (USD Million) 4.4.1.2 Real-Time PCR (qPCR or quantitative PCR) market, 2014 - 2025 (USD Million) Chapter 5 Malaria Diagnostics Market: Regional Estimates & Trend Analysis, by Technology 5.1 Malaria Diagnostics market share by region, 2017 & 2025 5.2 North America 5.2.1 Nigeria 5.2.2 Congo 5.2.3 Uganda 5.3 South East Asia 5.3.1 India 5.3.2 Myanmar 5.3.3 Indonesia 5.4 Eastern Mediterranean 5.4.1 Saudi Arabia 5.4.2 Pakistan
Follow Us:
5.5 Western Pacific 5.5.1 China 5.5.2 Papua New Guinea 5.5.3 Cambodia 5.6 Americas 5.6.1 Venezuela 5.6.2 Brazil 5.6.3 Colombia 5.7 Europe 5.7.1 Turkey 5.7.2 France 5.7.3 U.K. 5.7.4 Germany Chapter 6 Competitive Landscape 6.1 Company Profiles 6.1.1 Access Bio, Inc. 6.1.1.1 Company overview 6.1.1.2 Product benchmarking 6.1.1.3 Strategic initiatives 6.1.2 Abbot 6.1.2.1 Company overview 6.1.2.2 Financial performance 6.1.2.3 Product benchmarking 6.1.2.4 Strategic initiatives 6.1.3 Premier Medical Corporation Ltd. 6.1.3.1 Company overview 6.1.3.2 Product benchmarking 6.1.4 Sysmex Partec GmbH 6.1.4.1 Company overview 6.1.4.2 Financial performance 6.1.4.3 Product benchmarking 6.1.5 bioMerieux
Follow Us:
6.1.5.1 Company overview 6.1.5.2 Product benchmarking 6.1.5.3 Strategic initiatives 6.1.6 Beckman Coulter, Inc. 6.1.6.1 Company overview 6.1.6.2 Financial performance 6.1.6.3 Product benchmarking 6.1.6.4 Strategic initiatives 6.1.7 Siemens Healthineers 6.1.7.1 Company overview 6.1.7.2 Financial performance 6.1.7.3 Product benchmarking 6.1.8 Leica Microsystems GmbH 6.1.8.1 Company overview 6.1.8.2 Financial performance 6.1.8.3 Product benchmarking 6.1.8.4 Strategic initiatives 6.1.9 Nikon Corporation 6.1.9.1 Company overview 6.1.9.2 Financial performance 6.1.9.3 Product benchmarking 6.1.9.4 Strategic initiatives 6.1.10 Olympus Corporation 6.1.10.1 Company overview 6.1.10.2 Financial performance 6.1.10.3 Product benchmarking 6.1.10.4 Strategic initiatives 6.1.11 Bio-Rad Laboratories, Inc. 6.1.11.1 Company overview 6.1.11.2 Financial performance 6.1.11.3 Product benchmarking
Follow Us:
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us: